Synthesis Institute

Synthesis Institute

Psychedelic retreat utilising psilocybin truffles. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€26—40m (Dealroom.co estimates Sep 2021.)
Company register number 72275316
Zandvoort North Holland (HQ)
  • Edit
DateInvestorsAmountRound
-

N/A

-

$2.8m

Seed
N/A

$7.3m

Series A
*
N/A

N/A

Bankruptcy
Total Funding€9.1m

Recent News about Synthesis Institute

Edit
More about Synthesis Instituteinfo icon
Edit

Synthesis Retreat operates in the wellness and mental health market, offering guided group psychedelic retreats aimed at enhancing mental health and emotional stability. The company serves individuals seeking personal growth, emotional healing, and mental well-being through scientifically-backed psychedelic experiences. Synthesis Retreat's business model revolves around organizing and facilitating these retreats, providing a structured environment where participants can safely explore the therapeutic potential of psychedelics. Revenue is generated through retreat fees, which cover accommodation, guided sessions, and integration support. The company leverages scientific research and expert insights to ensure a transformative experience for its clients, emphasizing the importance of preparation and integration in the psychedelic journey.

Keywords: psychedelic retreats, mental health, emotional stability, personal growth, wellness, guided sessions, scientific research, integration support, therapeutic potential, group experiences.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.